Giuseppina Pichiri
Overview
Explore the profile of Giuseppina Pichiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pichiri G, Piludu M, Congiu T, Grandi N, Coni P, Piras M, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861074
The primary method used to pharmacologically arrest cancer development and its metastasis is to disrupt the cell division process. There are a few approaches that may be used to meet...
2.
Faa G, Messana I, Coni P, Piras M, Pichiri G, Piludu M, et al.
Cells
. 2024 Jul;
13(13.
PMID: 38994967
This review summarizes the results of a series of studies performed by our group with the aim to define the expression levels of thymosin β and thymosin β over time,...
3.
Coni P, Piras M, Piludu M, Lachowicz J, Matteddu A, Coni S, et al.
J Public Health Res
. 2023 Jan;
12(1):22799036221150332.
PMID: 36712902
Background: Breakthrough studies have shown that pluripotent stem cells are present in human breast milk. The expression of pluripotency markers by breast milk cells is heterogeneous, relating to cellular hierarchy,...
4.
Piludu M, Pichiri G, Coni P, Piras M, Congiu T, Faa G, et al.
Int Immunopharmacol
. 2023 Jan;
116:109743.
PMID: 36706591
Cell metastasis is the main cause of cancer mortality. Inhibiting early events during cell metastasis and invasion could significantly improve cancer prognosis, but the initial mechanisms of cell transition and...
5.
Piras M, Gerosa C, Congiu T, Cau F, Fanni D, Pichiri G, et al.
J Public Health Res
. 2022 Oct;
11(4):22799036221124076.
PMID: 36310827
Background: A complex sequence of morphogenetic events leads to the development of the adult mouse kidney. In the present study, we investigated the morphological events that characterize the early stages...
6.
Thymosin β4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study
Coni P, Piras M, Mateddu A, Piludu M, Orru G, Scano A, et al.
RSC Adv
. 2022 May;
10(21):12680-12688.
PMID: 35497634
Biomarkers of cell stress are important for proper diagnosis, and in studies of how cells respond to drug treatment. Biomarkers that respond early to pharmacological treatment could improve therapy by...
7.
Lachowicz J, Mateddu A, Coni P, Caltagirone C, Murgia S, Gibson D, et al.
Dalton Trans
. 2022 Apr;
51(16):6254-6263.
PMID: 35373808
Metal ions have unique electrochemical and spectroscopical properties that cannot be attained by purely organic compounds. Most of the metal ions are toxic to humans, but paradoxically, metallodrugs are used...
8.
Coni P, Pichiri G, Lachowicz J, Ravarino A, Ledda F, Fanni D, et al.
Molecules
. 2021 Nov;
26(21).
PMID: 34771023
Zinc is the second most abundant trace element in the human body, and it plays a fundamental role in human physiology, being an integral component of hundreds of enzymes and...
9.
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells
Congiu T, Alghrably M, Emwas A, Jaremko L, Lachowicz J, Piludu M, et al.
Pharmaceutics
. 2021 Jul;
13(6).
PMID: 34204936
In recent decades, type 2 diabetes complications have been correlated with amylin aggregation, copper homeostasis and metformin side effects. However, each factor was analyzed separately, and only in some rare...
10.
Emwas A, Alghrably M, Dhahri M, Sharfalddin A, Alsiary R, Jaremko M, et al.
Ageing Res Rev
. 2021 Jun;
70:101391.
PMID: 34119687
Conformational diseases are caused by the aggregation of misfolded proteins. The risk for such pathologies develops years before clinical symptoms appear, and is higher in people with alpha-1 antitrypsin (AAT)...